Status:
COMPLETED
Digital Detection of Dementia (D Cubed) Studies: D2
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease and Related Dementias (ADRD)
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD...
Detailed Description
Alzheimer's disease and related dementias (ADRD) negatively impact millions of Americans with an annual societal cost of more than $200 million.1 Currently, half of Americans living with ADRD never re...
Eligibility Criteria
Inclusion
- 65 years or older
- At least one visit to primary care practice within the past year
- Ability to provide informed consent
- Ability to communicate in English or Spanish
- Available EHR data from at least the past three years
Exclusion
- Prior ADRD or mild cognitive impairment diagnosis as determined by ICD-10 code
- Evidence of any history of prescription for a cholinesterase inhibitors or memantine.
- Has serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code
- Permanent resident of a nursing facility
Key Trial Info
Start Date :
July 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2024
Estimated Enrollment :
5325 Patients enrolled
Trial Details
Trial ID
NCT05231954
Start Date
July 5 2022
End Date
July 5 2024
Last Update
August 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University
Indianapolis, Indiana, United States, 46202